SENSEX NIFTY

Api

May 23, 2016 at 16:31 | Source: Moneycontrol.com
Analysts polled by CNBC-TV18 say that Cipla is ikely to meet FY16 guidance of 15 percent growth and 150 basis points (bps margin expansion. The company is likely to guide for 20 percent sales growth for FY17 on account of support from Invagen.
May 17, 2016 at 14:18 | Source: Moneycontrol.com
Apis India Ltd has informed BSE that the meeting of Board of Director of the Company is scheduled to be held on May 28, 2016, inter alia, to consider and approve the Audited Financial Results for the Quarter and the Financial Year ended on March 31, 2016 along with Audited Report thereon.
May 17, 2016 at 11:23 | Source: CNBC-TV18
Drugs for ailments like malaria and HIV are well-accepted in the market and it'll be an advantage for Mangalam Drugs, says Managing Director Govardhan Dhoot.
Apr 29, 2016 at 14:56 | Source: PTI
In 2013, government had constituted a high level committee headed by V M Katoch to study the whole issue of active pharmaceutical ingredients (APIs) of critical importance.
Apr 21, 2016 at 14:36 | Source: PTI
Anuh Pharma today said the WorldHealth Organisation (WHO) has suspended its products --Pyrazinamide and Sulfadoxine -- from prequalified list ofactive pharmaceutical ingredients (API).
Apr 19, 2016 at 14:00 | Source: PTI
The government had earlier said "it is examining the recommendations of the committee which has recommended establishment of mega parks for APIs with common facilities".
Apr 13, 2016 at 09:39 | Source: Moneycontrol.com
"Shilpa received GMP compliance certificate for two active pharmaceutical ingredient (API) sites from Pharmaceuticals and Medical Devices Agency, Japan," the Karnataka based pharma company said.
Apr 11, 2016 at 12:52 | Source: Moneycontrol.com
"Orchid received the establishment inspection report (EIR) from US Food and Drug Administration based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram district, Tamil Nadu," says the pharma company in its filing.
Apr 11, 2016 at 12:50 | Source: PTI
"Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram district. The facility was inspected by USFDA in the month of August 2015," the company said in a BSE filing today.
Apr 11, 2016 at 11:44 | Source: Moneycontrol.com
Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015.
Messages on Api »

shmarketgen
ius

Platinum Member

736 Followers

Granules India  

How sustainable are the margins? Granules talks similar to Motherson...they both emphasize `efficiency` a lot.And rightfully so,an efficient usage of capacity & distribution network will enhance the revenues,without even demand rising up much! The China competition is receding in APIs

3.51 PM Jul 8th 2014

Neha-Diwan

Platinum Member

4564 Followers

Shasun Pharma  

Shasun Pharmaceuticals soars on completing USFDA inspection at API unit in Tamil Nadu.

1.28 PM Jul 8th 2014

countryman

Platinum Member

1179 Followers

Granules India  

Granules has five facilities as well as two additional facilities through its JVs • Granules’ Facilities (5) 1. Gagillapur – Finished Dosage and PFI 2. Bonthapally – Dedicated Paracetamol API Facility 3. Jeedimetla – Multi-Product API and PFI Facility 4. Bonthapally (Auctus) – Intermediate

12.50 PM Jul 8th 2014

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th 2014

Expert Chartist

Platinum Member

13126 Followers

Agio Paper  

At 10:49 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 8th 2014

venkatagopa
l

Platinum Member

628 Followers

Orchid Chemical  

drug API business and becoming smaller in size without reduction of equity. Promoters r at advantage at the cost of investors. But no problem to investors who entered since six months after THE crash! We have to see whether profit booking is taking place or new investment is coming! In quarter from

3.57 PM Jul 7th 2014

Expert Chartist

Platinum Member

13126 Followers

Agio Paper  

At 10:59 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 7th 2014

Expert Chartist

Platinum Member

13126 Followers

Agio Paper  

At 10:42 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 4th 2014

sumkohli

New Member

0 Follower

Unitech  

Drama itna touchy ho rahe ho to jaa kar api securities agency khol lo and keep advising your client for all the longs and shorts.

3.30 PM Jul 3rd 2014

MCX GURU BHAI

Platinum Member

6194 Followers

Commodities  

kareena ji the crude fall was due to bad ism manufacturing data not about api data and as per u if it`s sue to that could you tell me how and what sign shows that

11.54 PM Jul 1st 2014

News across the web »
May 26, 2016 at 08:26 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.